TP53 and carcinoma: At the level of early neoplastic progression many colorectal tumors share canonical initiating events of the adenoma–carcinoma sequence (for example, alterations of APC, early KRAS activation and subsequent TP53 inactivation), indicating a broadly conserved “early” genetic program across colon and rectum [56].